Clinical Trial Update: CURE-H. Pylori: A Trial on the Combination of Anti-Ulcerants and Levofloxacin-Based Therapy for Helicobacter Pylori Eradication [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a combination of anti-ulcerants and a levofloxacin-based therapy for Helicobacter pylori eradication; recruitment is ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis Helicobacter Pylori-associated
• Helicobacter Pylori Infection
• Peptic Ulcer Disease Helicobacter Pylori-associated

Drugs mentioned

• Levofloxacin (Levofloxacin)

Snippet

Sponsor: Dow University of Health Sciences | Conditions: H. Pylori Gastrointestinal Disease, H.Pylori Infection | Phase 4 | Status: RECRUITING